ABSTRACT. A dramatic rise in the number of resistant Campylobacter to quinolones has been documented in human patients and domestic animals. In this study, the mechanism of acquisition of quinolone resistance was studied by detecting point mutations in the gyrA gene of Campylobacter strains obtained from broilers and strains with in vitro-induced resistance. The minimal inhibitory concentrations (MICs) of norfloxacin (NFLX) and ofloxacin (OFLX) for the strains that had no point mutation were slightly increased from the so urce strain (Campylobacter jejuni ATCC 33560). The MICs of nalidixic acid (NA), NFLX, and OFLX for the strains that had the point mutation at Thr-86 were 100 or 200 µg/ml, 50 µg/ml, and 25 µg/ml, respectively. The MIC of NA for the strain that had a point mutation at Asp-90 higher than those for the strains that had the point mutation at Thr-86, but the MICs of NFLX and OFLX were relatively lower than those for the strains that had point mutation at Thr-86. These findings suggest that the degree of antimicrobial resistance against NA, NFLX, and OFLX in the in vitro-induced C. jejuni strains was associated with the location of the point mutation in gyrA. On the other hand, a point mutation in all seven resistant strains isolated from broilers was located only at Thr-86, while the MICs of the three quinolones varied in each wild strain. This suggests that another mechanism might also be involved in the acquisition of quinolone resistance in C. jejuni wild strains.
Campylobacter species are recognized as a frequent cause of human diarrhea [2, 18] . Quinolones were proposed for the first choice in the treatment of Campylobacter enteritis in the 1980s because these agents demonstrated an excellent in vitro susceptibility against Campylobacter jejuni and/or Campylobacter coli [10, 11, 16] , and quinoloneresistant C. jejuni and C. coli strains were not recognized at that time. However, several subsequent reports have described the emergence of quinolone-resistant Campylobacter isolates after therapy with quinolones [1, 23] . Since the late 1980s, resistance to quinolones in human Campylobacter isolates has been recognized in many countries including Spain [22] , Finland [19] , Austria [9] and the Netherlands [8] . In Japan, C. jejuni and C. coli isolated from humans, cattle, pigs and broilers between 1979 and 1982 were all susceptible to quinolones [21] , whereas resistant isolates have been recognized in human patients since 1989 and the resistance rate is increasing [24] . Quinolone-resistant C. jejuni and C. coli were also isolated from broilers in our previous survey between 1995 and 1999 [5] .
The mechanisms of bacterial resistance to fluoroquinolones include point mutations of DNA gyrase, the target of the drugs, or decreased accumulation in the bacterial cell due to reduced permeability of the cell membrane and hyperfunction of the efflux pump. Wang et al. [25] cloned and sequenced the gyrA gene of C. jejuni that encodes a subunit of DNA gyrase and identified substitutions of Thr-86, Asp-90 and Ala-70 of the GyrA protein in laboratory mutants of C. jejuni with high-level fluoroquinolone resistance. Several other reports [20, 26, 28] have pointed out that mutation at Thr-86 in clinical isolates of C. jejuni is frequently associated with the acquisition of a high level of resistance to quinolones. However, the association between degree of quinolone resistance and other point mutations has not been investigated.
Recently, a rapid and simple assay based on PCR amplification and digestion of the PCR product with some restriction enzymes has been developed to identify the region of the gene containing the mutation sites [7, 13] . In this study, this assay system was used for the detection of mutations within Thr-86 and also the Asp-90 and Ala-70 codons of C. jejuni gyrA. The association between acquisition of quinolone resistance and the location of the point mutation was investigated in wild strains and C. jejuni strains with in vitro-induced fluoroquinolone resistance.
MATERIALS AND METHODS
Bacterial strains: Twenty-four wild strains of C. jejuni that showed four patterns of quinolone-susceptibility (Table  1) were used in this study. Two strains were resistant to nalidixic acid (NA) and norfloxacin (NFLX), two were 9 bacterial cells were inoculated on the surface of MH agar plates containing NA (12.5, 25, 50 or 100 µg/ml), OFLX (0.39, 0.78, 1.56, 3.13 or 6.25 µg/ml), or NFLX (0.78, 1.56, 3.13, 6.25 or 12.5 µg/ml). A single colony was picked from each plate and cloned by subculturing on intact MH agar. Each strain was stored at -80°C.
The minimal inhibition concentrations (MIC) determinations:
The MICs of the antimicrobial agents for each strain were determined by the agar dilution method as described previously [24] . In brief, each strain was cultured in brain heart infusion broth for 24 hr at 37°C with shaking under microaerophilic conditions, and an inoculum of approximately 10 4 colony-forming units per spot was applied with a multiple inoculator onto MH agar plates containing serial two-fold dilutions of NA, OFLX and NFLX (Sigma Chemical Co., St. Louis, Mo., U.S.A.). The MIC was defined as the lowest concentration of the agent that completely inhibited visible growth of the inoculum after incubation for 48 hr at 37°C.
Detection of point mutations in the gyrA gene: Twentytwo strains of C. jejuni were used for the detection of point mutations. C. jejuni ATCC 33560 was used as the standard strain through the experiment. Seven strains were wild quinolone-resistant strains isolated from cecal contents of broilers. Fourteen were in vitro-induced quinolone-resistant strains derived from the standard strain. The rapid assay for point mutations described by Deguchi et al. [7] was applied for C. jejuni. Primer GY3 was used as the sense primer (Fig.  1) . Antisense primers A70Alu, T86Pvu and D90Hinf were made adjacent to the mutation sites within the Ala-70, Thr-86 and Asp-90 codons with each nucleotide sequence differing by one base from the nucleotide sequence to create each new cleavage site. Figure 2 demonstrates how the point mutation within the Ala-70 codon was detected. Point mutations within the Thr-86 and Asp-90 codons were detected in the same way. Template DNA was prepared from a suspension of bacteria cultured in brain heart infusion broth with shaking. A volume of 1 ml of the bacterial suspension was transfered into a 1.5-ml microtube, which was centrifuged at 6,400 rpm for 5 min. The pellet was suspended in 300 µl of buffer solution (50 mM Tris-HCl and 20 mM EDTA, pH 8.0) containing 2% sodium dodecyl sulfate and proteinase K (100 µg/ml). The mixture was incubated at 60°C for 1 hr and allowed to stand on ice for 10 min. Saturated NaCl solution (130 µl) was added to the suspension and it was kept on ice for 5 min. The mixture was centrifuged at 12,000 rpm for 10 min at 4°C and the supernatant was extracted twice with an equal volume of phenol-chloroform-isoamylalcohol solution (25:24:1). The purified DNA was ethanol-precipitated, rinsed with 70% ethanol and dis- . Glycogen (1 µl, 20 mg/ml) (Boehringer Mannheim GmbH, Mannheim, Germany) was added, and the DNA was precipitated with two volumes of ethanol containing sodium acetate, rinsed with 70% ethanol and dissolved in distilled water. The DNA was digested with the appropriate units of restriction enzymes AluI, PvuII, or HinfI (Takara Shuzo Co., Otsu, Japan). The digested DNA was analyzed by electrophoresis in 3% NuSieve GTG agarose gel (FMC BioProducts, Rockland, Me., U.S.A.) at 100 V for 2 hr. A 100-bp DNA ladder was used as the standard molecular-size marker. DNA bands were visualized with an ultraviolet transilluminator and photographed.
RESULTS

MICs of quinolones against in vitro-induced resistant strains and wild strains:
The MICs of the quinolones for the in vitro-induced resistant strains are shown in Table 2 . MICs of NA, OFLX and NFLX for the standard strain, estimated by agar dilution, were 12.5, 0.39 and 0.78 µg/ml, respectively. The MICs of the three quinolones for strain N-01 were very low but they were slightly higher than those of the standard strain. The MIC of NA against strains NA-01 and NA-02 was high (100 µg/ml) but the MICs of NFLX and OFLX were low (3.13 µg/ml). The MIC of NA for strain NA-04 was extremely high (400 µg/ml) but the MICs of NFLX and OFLX were moderate as 25 µg/ml and 12.5 µg/ml, respectively. The MICs of the three quinolones for the other strains were all high.
The MICs of the quinolones for the wild strains are shown in Table 3 . Strains A-1 and A-2 were sensitive to OFLX by the disk diffusion method (Table 1 ) with a MIC of 12.5 µg/ml. Strains B-1 and B-2 were sensitive to NA by disk diffusion (Table 1 ) with a MIC of 50 µg/ml. Various MIC patterns were observed in the seven wild strains. Figure  3 apart from thymine at the position indicated by the asterisk. During PCR, the modified primer introduces an adenine in place of guanine into the PCR product. When a DNA fragment is amplified from a wild-type gyrA gene by PCR, introduction of adenine creates a AluI restriction site. Consequently, the PCR product (74 bp) has the artifical AluI restriction site in the region containing Ala-70 , which produces two fragments upon AluI restriction enzyme digestion. On the other hand, the PCR product that has no AluI restriction site (74 bp) indicates a point mutation at the location of guanine (arrowhead).
Point mutations in the gyrA gene of in vitro-induced quinolone-resistant strains and wild strains of C. jejuni:
(E: lanes 6~9), and O-01~05 (K: lanes 10~14). A point mutation at Asp-90 was found in strain NA-04 (C: lane 4). The point mutation at Thr-86 was also found in the seven wild strains (K: lanes 15~21). The locations of all point mutations are shown in the right end columns of Tables 2  and 3 .
DISCUSSION
Quinolones are used in the therapy of a wide variety of bacterial infections in humans and animals. However, a previous study [15] showed that quinolone resistance in Campylobacter was induced by quinolone treatment of Campylobacter-colonized broilers and that quinolone treatment did not eradicate Campylobacter colonization in the broilers. Gootz and Martin [12] selected quinolone-resistant isolates by plating bacterial cells from a susceptible C. jejuni strain on medium containing NA at 32 µg/ml and demonstrated that spontaneous resistant mutants arose at a frequency of approximately 5 × 10 -8 per cell plated. In the current study, quinolone-resistant mutants were selected at almost the same frequency. It therefore seems as if C. jejuni acquire quinolone resistance relatively easily. Mutations in gyrA have been found in a variety of bacteria including Staphylococcus aureus [14] , Escherichia coli [6] , Salmonella spp. [17] and C. jejuni [3] . After C. jejuni gyrA was cloned and sequenced [25] , a number of rapid methods for the detection of single nucleotide mutations of the gene without sequencing, including nonradioisotopic single-strand conformation polymorphism [3] and a mismatch amplification mutation PCR assay for the detection of the point mutation within the Thr-86 codon of C. jejuni gyrA [27] , were established. In this study, a rapid and simple assay system was developed for the detection of mutations within the Thr-86, Asp-90 and Ala-70 codons of C. jejuni gyrA.
Strains NA-01 and NA-02, which did not have any point mutations, were resistant only to NA. The MICs of the three quinolones increased slightly in strain N-01 but this strain was judged to be susceptible to all three quinolones. Ten strains that had a point mutation at Thr-86 were resistant to all three quinolones examined. The MICs of NA, NFLX and OFLX were 100 or 200 µg/ml, 50 µg/ml and 25 µg/ml, respectively. Strain NA-04 that had a point mutation at Asp-90 was also resistant to all three quinolones, but the MICs of the drugs were different (NA: 400 µg/ml, NFLX: 25 µg/ml, OFLX: 12.5 µg/ml) from those for other strains that had the point mutation at Thr-86. The MIC of NA for the strain NA-04 was considerably higher than those for the strains that had the point mutation at Thr-86, but the MICs of NFLX and OFLX were relatively lower than those for the strains that had point mutation at Thr-86. These findings suggest that the degree of antimicrobial resistance against NA, NFLX, and OFLX in the in vitro-induced C. jejuni strains was associated with the location of the point mutation in gyrA. On the other hand, a point mutation in all seven resistant strains isolated from broilers was located only at Thr-86, while the MICs of the three quinolones varied in each wild strain. This suggests that another mechanism might also be involved in the acquisition of quinolone resistance in C. jejuni wild strains.
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